As human cases of avian influenza slowly tick up amid the outbreak in U.S. dairy cattle, the Centers for Disease Control and Prevention (CDC) and Moderna have teamed up to design an mRNA vaccine ...

If you believe in the work we do at Vox, please support us by becoming a member. Our mission has never been more urgent. But our work isn’t easy. It requires resources, dedication, and independence.

Moderna, a leader in mRNA medicine, developed one of the earliest COVID-19 vaccines, with Spikevax being its first commercial product. The company's mRNA platform enables the development of ...

The post-pandemic economy has not been kind to COVID-19 vaccine maker Moderna. The Cambridge-based biotech has faced a slew of challenges resulting in over a 60% drop in share value year-to-date. As ...

Infants are among the most vulnerable when it comes to RSV—but there's still no vaccination for them. A pediatric vaccine for respiratory syncytial virus (RSV) is proving to be elusive ...

Sandisk Corporation, the maker of flash drives and memory cards, debuted a new logo today, and it’s based on a single pixel. “It all started with the pixel, which is the fundamental smallest ...

In September, Moderna unveiled key updates at its annual R&D Day, spotlighting its mRNA-based pipeline and revised financial plans. The company has witnessed a decline in its only approved ...

As a result, Moderna Inc. (NASDAQ:MRNA) was removed from the index. Year to date, Moderna stock has plunged over 60%, with a 52-week low-high of $35.8-$170.47, as per data from Benzinga Pro.

In the US, citizens can pick between vaccines manufactures by Moderna, Pfizer and Novavax. According to CDC data, in about one in every 200,000 cases, a person develops an allergic reaction ...

The early winners won big — especially the WFH plays like Zoom and Peloton, and, of course, vaccine makers like Pfizer and Moderna. All of these stocks have all had a rocky path back to ...

The halt was triggered by an “imbalance,” the FDA said, in cases of severe lower respiratory tract infections (LRTIs) in children in a phase 1 trial of two Moderna RSV vaccines. One of the ...